EUVIMEDEUVIMED entdecken
Crossref

Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia

Yuen Kang Joseph Yeoh, Gregory J Dore iD, Ian Lockart iD, Mark Danta iD, Ciara Flynn, Conner Blackmore iD, Miriam T Levy iD, Jacob George iD, Maryam Alavi iD, Behzad Hajarizadeh iD

Internal Medicine Journal · 2024

DOI: 10.1111/imj.16252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, 2024. Verfasst von Yuen Kang Joseph Yeoh und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Kirby Institute, UNSW, New South Wales, Sydney, Australia. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Non-alcoholic Fatty Liver Disease, Hepatitis C, Chronic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Australian Government Department of Health and Ageing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Viral hepatitis, alcohol‐related liver disease (ARLD) and nonalcoholic fatty liver disease (NAFLD) are the main risk factors for hepatocellular carcinoma (HCC) in many countries. In Australia, given the access to hepatitis C virus (HCV) direct‐acting antiviral (DAA) therapy since 2016, a temporal change in HCC aetiology was hypothesized. This study evaluated the temporal change in the aetiology and characteristics of HCC in New South Wales (NSW).

Methods

Patients diagnosed with HCC, admitted to three public hospitals in NSW between 2008 and 2021, were included in the analyses. We assessed the annual frequency of each HCC aetiology and the distribution of HCC characteristics in participants.

Results

Among 1370 patients, the most common HCC etiologies were HCV ( n = 483, 35%), ARLD ( n = 452, 33%), NAFLD ( n = 347, 25%) and hepatitis B virus ( n = 301, 22%). The proportion of HCV‐related HCC was the highest in 2011–2016 (41%) and significantly declined to 30% in 2017–2021 (odds ratio [OR], 0.53 [95% confidence interval (CI), 0.35–0.79]; P = 0.002). The proportion of HCC diagnosed at an early stage (Barcelona Clinic Liver Cancer stage O/A) increased from 41% in 2008–2009 to 56% in 2020–2021 (OR per annum , 1.05 [95% CI, 1.02–1.08]; P = 0.002), and the proportion of patients receiving potentially curative HCC management increased from 29% in 2008–2009 to 41% in 2020–2021 (OR per annum , 1.06 [95% CI, 1.03–1.10]; P < 0.001).

Conclusion

The contribution of HCV to HCC burden has been decreasing in the DAA era, suggesting the role of HCV elimination in decreasing HCC risk. Increasing frequency of less advanced HCC at diagnosis over time suggests improved HCC surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsNon-alcoholic Fatty Liver DiseaseHepatitis C, ChronicHepatitis CHumansAntiviral AgentsNew South WalesAustraliaHepacivirus

Stichwörter der Autor:innen

HBVHCVepidemiologyhepatitisliver cancer

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • The Kirby Institute, UNSW, New South Wales, Sydney, Australia.
  • St Vincent's Hospital, Sydney, New South Wales, Australia.
  • St Vincent's Clinical School, UNSW, New South Wales, Sydney, Australia.
  • Liverpool Hospital, Sydney, New South Wales, Australia.
  • South Western Clinical School, UNSW, New South Wales, Sydney, Australia.
  • Storr Liver Centre, Westmead Hospital and The Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: Gregory J Dore, Ian Lockart, Mark Danta, Conner Blackmore, Miriam T Levy, Jacob George, Maryam Alavi, Behzad Hajarizadeh

Förderung

  • Australian Government Department of Health and Ageing

Zitieren

APA

Yeoh, Y. K. J., Dore, G. J., Lockart, I., Danta, M., Flynn, C., Blackmore, C., Levy, M. T., George, J., Alavi, M., & Hajarizadeh, B. (2024). Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia. Internal Medicine Journal. https://doi.org/10.1111/imj.16252

Vancouver

Yeoh YKJ, Dore GJ, Lockart I, Danta M, Flynn C, Blackmore C, et al. Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia. Internal Medicine Journal. 2024. doi:10.1111/imj.16252

BibTeX
@article{Yeoh2024,
  author = {Yeoh, Yuen Kang Joseph and Dore, Gregory J and Lockart, Ian and Danta, Mark and Flynn, Ciara and Blackmore, Conner and Levy, Miriam T and George, Jacob and Alavi, Maryam and Hajarizadeh, Behzad},
  title = {Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia},
  journal = {Internal Medicine Journal},
  year = {2024},
  doi = {10.1111/imj.16252}
}
Kostenlos starten →